SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-076406
Filing Date
2022-03-16
Accepted
2022-03-15 19:21:02
Documents
14
Period of Report
2022-03-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d324168d8k.htm   iXBRL 8-K 24558
2 EX-99.1 d324168dex991.htm EX-99.1 6558
6 GRAPHIC g324168page1.jpg GRAPHIC 5116
  Complete submission text file 0001193125-22-076406.txt   162965

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220310.xsd EX-101.SCH 2893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220310_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220310_pre.xml EX-101.PRE 11286
8 EXTRACTED XBRL INSTANCE DOCUMENT d324168d8k_htm.xml XML 3335
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 22742810
SIC: 2834 Pharmaceutical Preparations